Carolyn J Brown1. 1. Department of Speech Pathology and Audiology, University of Iowa, Iowa City 52242, USA. Carolyn-brown@uiowa.edu
Abstract
PURPOSE OF REVIEW: The purpose of this review is to summarize current thinking relative to clinical applications for the electrically evoked compound action potential and the electrically evoked auditory brainstem response with the focus on works published between 1998 and 2003. RECENT FINDINGS: During the period of this review, a considerable body of research has been published describing how the electrically evoked compound action potential can be measured and how the electrically evoked compound action potential may be used in the clinical treatment of cochlear implant patients. During this same period, there has been a decline in the number of studies reporting potential clinical applications for the electrically evoked auditory brainstem response. Perhaps the strongest clinical application for the electrically evoked compound action potential today is as a tool to facilitate the process of fitting the speech processor of the cochlear implant. This is particularly important for pediatric patients who may not be able to be programmed using traditional behavioral techniques. The accuracy of these predictions is discussed in addition to the limitations of the studies reviewed. SUMMARY: The introduction of cochlear implants with the capability of measuring the response of the auditory nerve to electrical stimulation from an intracochlear electrode has tremendous potential to impact clinical practice. Research into how best to use this information is ongoing.
PURPOSE OF REVIEW: The purpose of this review is to summarize current thinking relative to clinical applications for the electrically evoked compound action potential and the electrically evoked auditory brainstem response with the focus on works published between 1998 and 2003. RECENT FINDINGS: During the period of this review, a considerable body of research has been published describing how the electrically evoked compound action potential can be measured and how the electrically evoked compound action potential may be used in the clinical treatment of cochlear implant patients. During this same period, there has been a decline in the number of studies reporting potential clinical applications for the electrically evoked auditory brainstem response. Perhaps the strongest clinical application for the electrically evoked compound action potential today is as a tool to facilitate the process of fitting the speech processor of the cochlear implant. This is particularly important for pediatric patients who may not be able to be programmed using traditional behavioral techniques. The accuracy of these predictions is discussed in addition to the limitations of the studies reviewed. SUMMARY: The introduction of cochlear implants with the capability of measuring the response of the auditory nerve to electrical stimulation from an intracochlear electrode has tremendous potential to impact clinical practice. Research into how best to use this information is ongoing.
Authors: Paola V Incerti; Teresa Y C Ching; Sanna Hou; Patricia Van Buynder; Christopher Flynn; Robert Cowan Journal: Int J Audiol Date: 2017-09-08 Impact factor: 2.117
Authors: Amanda Christina Gomes de Moura; Maria Valéria Schmidt Goffi-Gomez; Maria Ines Vieira Couto; Rubens Brito; Robinson Koji Tsuji; Debora Maria Befi-Lopes; Carla Gentile Matas; Ricardo Ferreira Bento Journal: Int Arch Otorhinolaryngol Date: 2014-07-17